Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients
As the survival rate of cardiac recipients improves, higher incidence of malignancy in the late postoperative period becomes essential for their prognosis. Immunosuppressive therapy is one of the key prerequisites for successful transplantation. However, long-term use of immunosuppressive agents inc...
Saved in:
| Main Authors: | L. B. Krougly, N. N. Koloskova, A. V. Nikulin, I. V. Pashkov, V. N. Poptsov, A. O. Shevchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2021-07-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung cancer in solid organ transplant recipients
by: A. V. Nikulin, et al.
Published: (2022-01-01) -
THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01) -
Post-transplant malignancies in solid organ recipients: development mechanisms and risk factors
by: A. V. Nikulin, et al.
Published: (2021-09-01) -
Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01) -
Evaluation of the results of treatment of kidney recipients at the outpatient stage against the background of minimizing immunosuppressive therapy
by: E. V. Parabina, et al.
Published: (2023-10-01)